UK markets open in 6 hours 43 minutes

International Biotechnology Trust plc (IBT.L)

LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Add to watchlist
618.00+2.00 (+0.32%)
At close: 04:28PM BST
Currency in GBp

Valuation measures4

Market cap (intra-day) 232.37M
Enterprise value N/A
Trailing P/E 36.69
Forward P/E 714.29
PEG ratio (5-yr expected) N/A
Price/sales (ttm)29.43
Price/book (mrq)0.86
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.21
52-week change 3-6.38%
S&P500 52-week change 323.10%
52-week high 3742.61
52-week low 30.00
50-day moving average 3650.97
200-day moving average 3629.28

Share statistics

Avg vol (3-month) 359.85k
Avg vol (10-day) 346.63k
Shares outstanding 537.72M
Implied shares outstanding 639.1M
Float 8N/A
% held by insiders 14.21%
% held by institutions 150.63%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.28
Forward annual dividend yield 44.51%
Trailing annual dividend rate 30.28
Trailing annual dividend yield 30.05%
5-year average dividend yield 44.19
Payout ratio 4167.96%
Dividend date 3N/A
Ex-dividend date 421 Dec 2023
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in GBP.

Fiscal year

Fiscal year ends 31 Aug 2023
Most-recent quarter (mrq)31 Aug 2023

Profitability

Profit margin 65.08%
Operating margin (ttm)126.01%

Management effectiveness

Return on assets (ttm)1.30%
Return on equity (ttm)2.45%

Income statement

Revenue (ttm)10.47M
Revenue per share (ttm)0.26
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA N/A
Net income avi to common (ttm)6.81M
Diluted EPS (ttm)0.17
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)N/A
Total cash per share (mrq)N/A
Total debt (mrq)32.47M
Total debt/equity (mrq)12.01%
Current ratio (mrq)0.09
Book value per share (mrq)6.88

Cash flow statement

Operating cash flow (ttm)27.3M
Levered free cash flow (ttm)13.89M